EMA accepts Astellas, Seagen's enfortumab vedotin application in urothelial cancer
March 26 2021 - 3:04AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024